How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery
GPT-5 Pro helped solve a 3-year-old immunology mystery, offering insights into T cell behavior. The breakthrough could support cancer and autoimmune research.
Learn how GPT-5.5 Instant improves ChatGPT’s health and wellness responses with stronger reasoning, better context, clearer communication, and physician-informed evaluations.
A near-autonomous AI chemist improves a challenging reaction in medicinal chemistry
OpenAI and Molecule.one show how a near-autonomous AI chemist using GPT-5.4 improved a key drug-making reaction, advancing medicinal chemistry research.
Introducing LifeSciBench, an expert-authored, expert-reviewed benchmark for evaluating how AI systems handle real-world life science research tasks and decisions.
PRC-linked influence operations are targeting AI debates in the US
A new report from OpenAI details PRC-linked influence operations using AI to target U.S. tech debates, data center narratives, tariffs, and false claims about ChatGPT.
From data to decisions: how LSEG is scaling trusted AI
See how LSEG uses OpenAI to scale trusted AI across its global business, accelerating insights, shrinking release cycles, and empowering 4,000 employees.
OpenAI launches the Economic Research Exchange to study AI’s impact on jobs, productivity, and the economy. Applications are now open for selected research projects.
GPT-Rosalind advances life sciences research with enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
OpenAI outlines its public policy agenda for AI, including safety, youth protection, workforce transition, and global standards to ensure AI benefits society.
Our approach to AI policy and political advocacy, transparency, support for thoughtful regulation and AI safety, and that no outside political group speaks on the company’s behalf.
Boston Children’s Hospital uses OpenAI technology to improve patient care, reduce operational burden, and help diagnose more than 40 rare disease cases.
Strengthening societal resilience with Rosalind Biodefense
OpenAI launches Rosalind Biodefense, expanding trusted access to GPT-Rosalind for vetted developers and U.S. government partners advancing biodefense, public health, and pandemic preparedness through frontier AI.